AI | pharmaphorum

AI

Digital

Augmented intelligence is strategically valuable because it strengthens both the scientific and financial case for every decision.

Patients

Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.

News

Lundbeck has appointed Markus Kede to the newly created role of chief AI officer, charged with driving its ambition to become a 'bionic' company.

Digital

Explore an AI-powered 360 Medical Engagement vision that links engagement, insight, evidence, and strategy in a continuous loop.

Digital

Many biotechs remain locked out of the AI revolution by a combination of cost, complexity, and lack of access to state-of-the-art infrastructure.

Digital

For Inventus' Steve Sanghera and Jim Michel 2025 was a year of progress in clinical trial enablement.